Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-01

Clinical Trial Update: Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIV [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating the effect of steady-state tipranavir/ritonavir on intracellular zidovudine and abacavir levels in HIV-infected patients; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbovir (abacavir)
  • Zidovudine (Zidovudine)
  • tipranavir/ritonavir (tipranavir/ritonavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 1, Phase 2 | Status: TERMINATED